Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,734 | -3,884 | -16,055 | -12,592 | -8,958 |
| Depreciation Amortization | 58 | 28 | 111 | 83 | 54 |
| Accounts receivable | 144 | 160 | -145 | -145 | 14 |
| Other Working Capital | -246 | -284 | -1,011 | -645 | -364 |
| Other Operating Activity | 925 | 493 | 3,376 | 2,752 | 1,862 |
| Operating Cash Flow | $-5,853 | $-3,487 | $-13,724 | $-10,548 | $-7,391 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,231 | -302 | 7,441 | 5,098 | 1,422 |
| PPE Investments | -61 | -21 | -100 | -92 | -56 |
| Investing Cash Flow | $1,170 | $-323 | $7,341 | $5,006 | $1,366 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,124 | 5,109 | 5,969 | 5,951 | 5,724 |
| Financing Cash Flow | $5,124 | $5,109 | $5,969 | $5,951 | $5,724 |
| Beginning Cash Position | 1,649 | 1,649 | 2,063 | 2,063 | 2,063 |
| End Cash Position | 2,090 | 2,948 | 1,649 | 2,472 | 1,762 |
| Net Cash Flow | $441 | $1,299 | $-413 | $409 | $-301 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,853 | -3,487 | -13,724 | -10,548 | -7,391 |
| Capital Expenditure | -61 | -21 | -100 | -92 | -56 |
| Free Cash Flow | -5,913 | -3,508 | -13,824 | -10,640 | -7,447 |